Neurocrine Biosciences Inc

Vanguard Personalized Indexing Management, LLC NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

11,238

Value ($000)

1,594

Weight

0.0%

2021 Q2 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,594	0.0%	11,238	12/31/2025
2025 Q3	10/31/2025	1,560	0.0%	11,112	9/30/2025
2025 Q2	7/25/2025	1,387	0.0%	11,035	6/30/2025
2025 Q1	5/14/2025	935	0.0%	8,458	3/31/2025
2024 Q4	2/10/2025	1,512	0.0%	11,080	12/31/2024
2024 Q3	11/12/2024	1,068	0.0%	9,271	9/30/2024
2024 Q2	8/12/2024	1,235	0.0%	9,064	6/30/2024
2024 Q1	5/9/2024	1,205	0.0%	8,738	3/31/2024
2023 Q4	2/8/2024	1,430	0.0%	10,855	12/31/2023
2023 Q3	11/8/2023	1,475	0.0%	13,108	9/30/2023
2023 Q2	7/28/2023	1,162	0.0%	12,322	6/30/2023
2023 Q1	5/10/2023	1,227	0.0%	12,118	3/31/2023
2022 Q4	2/10/2023	1,393	0.1%	11,665	12/31/2022
2022 Q3	11/14/2022	1,186	0.1%	11,163	9/30/2022
2022 Q2	8/12/2022	1,102	0.1%	11,303	6/30/2022
2022 Q1	5/16/2022	1,046	0.1%	11,160	3/31/2022
2021 Q3	11/9/2021	320	0.0%	3,333	9/30/2021
2021 Q2	8/11/2021	655	0.1%	6,734	6/30/2021